Circulating betatrophin concentration is negatively correlated with insulin resistance in obese children and adolescents

Diabetes Research and Clinical Practice

Volumn 114, Issue , 2016, Pages 37-42

  Tuhan, Hale ^a   Abaci, Ayhan ^a   Anik, Ahmet ^a   Çatli, Gönül ^a   Küme, Tuncay ^a   Çalan, Özlem Gürsoy ^a   Acar, Sezer ^a   Böber, Ece ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Betatrophin; Childhood obesity; Insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETATROPHIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LIPASIN PROTEIN, HUMAN; LIPID; PEPTIDE HORMONE;

ADOLESCENT; ARTICLE; BODY FAT; BODY FAT PERCENTAGE; BODY MASS; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; SCHOOL CHILD; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DIET RESTRICTION;

ADOLESCENT; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; PEDIATRIC OBESITY; PEPTIDE HORMONES;

EID: 84959316124     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.02.008     Document Type: Article

References (24)

1. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384:766-781.
2. Falkner B., Michel S. Obesity and other risk factors in children. Ethn Dis 1999, 9:284-289.
3. Kelishadi R., Azizi-Soleiman F. Controlling childhood obesity: a systematic review on strategies and challenges. J Res Med Sci 2014, 19:993-1008.
4. Dali-Youcef N., Mecili M., Ricci R., Andres E. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med 2013, 45:242-253.
5. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Investig 2003, 112:1785-1788.
6. Yi P., Park J.S., Melton D.A. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 2013, 153:747-758.
7. Espes D., Lau J., Carlsson P.O. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2014, 57:50-53.
8. Espes D., Martinell M., Carlsson P.O. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014, 2014:323407.
9. Fenzl A., Itariu B.K., Kosi L., Fritzer-Szekeres M., Kautzky-Willer A., Stulnig T.M., et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 2014, 57:1204-1208.
10. Fu Z., Berhane F., Fite A., Seyoum B., Abou-Samra A.B., Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 2014, 4:5013.
11. Gomez-Ambrosi J., Pascual E., Catalan V., Rodriguez A., Ramirez B., Silva C., et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 2014, 99:E2004-E2009.
12. Hu H., Sun W., Yu S., Hong X., Qian W., Tang B., et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014, 37:2718-2722.
13. Wang Y., Quagliarini F., Gusarova V., Gromada J., Valenzuela D.M., Cohen J.C., et al. Mice lacking ANGPTL8 (betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 2013, 110:16109-16114.
14. Wu S., Gao H., Ma Y., Fu L., Zhang C., Luo X. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance. Pediatr Diabetes 2016, 17(1):53-60.
15. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 2012, 424:786-792.
16. Zhang R., Abou-Samra A.B. Emerging roles of lipasin as a critical lipid regulator. Biochem Biophys Res Commun 2013, 432:401-405.
17. Gokulakrishnan K., Manokaran K., Pandey G.K., Amutha A., Ranjani H., Anjana R.M., et al. Relationship of betatrophin with youth onset type 2 diabetes among Asian Indians. Diabetes Res Clin Pract 2015, 109:71-76.
18. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 2002, 11:1-190.
19. Valerio G., Licenziati M.R., Iannuzzi A., Franzese A., Siani P., Riccardi G., et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis NMCD 2006, 16:279-284.
20. Ren G., Kim J.Y., Smas C.M. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am Physiol Endocrinol Metab 2012, 303:E334-E351.
21. Fu Z., Abou-Samra A.B., Zhang R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 2014, 57:2232-2234.
22. Wong R.J., Ahmed A. Obesity and non-alcoholic fatty liver disease: disparate associations among Asian populations. World J Hepatol 2014, 6:263-273.
23. Liu L., Mei M., Yang S., Li Q. Roles of chronic low-grade inflammation in the development of ectopic fat deposition. Mediat Inflamm 2014, 2014:418185.
24. Catli G., Anik A., Tuhan H.U., Kume T., Bober E., Abaci A. The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children. Peptides 2014, 56:72-76.